SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 43 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $132,000 | -93.4% | 317,962 | -68.2% | 0.02% | -94.6% |
| Q3 2018 | $2,000,000 | -29.3% | 1,000,000 | -31.4% | 0.31% | -43.3% |
| Q3 2017 | $2,828,000 | -26.8% | 1,457,712 | +1.9% | 0.55% | -20.5% |
| Q2 2017 | $3,864,000 | -38.7% | 1,431,149 | -6.9% | 0.69% | -44.7% |
| Q1 2017 | $6,305,000 | +13.3% | 1,537,873 | 0.0% | 1.25% | +9.4% |
| Q4 2016 | $5,567,000 | +19.8% | 1,537,873 | +44.6% | 1.14% | -3.5% |
| Q3 2016 | $4,648,000 | – | 1,063,573 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|